Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer With Bone MetastasesOncologist 2020 May 28;[EPub Ahead of Print], J Xu, MJ Higgins, SM Tolaney, SE Come, MR Smith, M Fornier, U Mahmood, J Baselga, BY Yeap, BA Chabner, SJ Isakoff
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.